Abstract: The invention relates to compositions and methods for the treatment of gastric and/or duodenal H. pylori infections. The composition may include one or more of a proton pump inhibitor in a systemically available dosage form; a mucolytic preparation; a proton pump inhibitor in a gastrically available dosage form; and a fatty acid and/or monoglyceride.